Latest Regulatory Approval News

Algorae Pharmaceuticals has partnered with Peter MacCallum Cancer Centre to validate AI-predicted drug combinations across multiple cancer types, aiming to accelerate its oncology pipeline development.

Memphasys Limited has successfully trialed its RoXsta™ Mega Cell High-Throughput Assay, capable of processing 96 antioxidant tests in under an hour, promising a leap forward in rapid, cost-effective oxidative stress analysis.

Critical Resources Limited has lodged applications to begin maiden drilling at two promising antimony-gold targets within its Halls Peak Project in NSW, aiming to unlock significant mineral potential near Australia’s largest known antimony-gold system.

Regis Healthcare reveals strong first-half FY25 financial results with rising occupancy and earnings, while gearing up for significant regulatory reforms under the new Aged Care Act effective July 2025.

Southern Cross Gold Consolidated has successfully closed the first tranche of a private placement, raising C$88.8 million to advance its Sunday Creek Gold-Antimony Project in Victoria, Australia. The funds will support drilling, resource definition, and early development milestones.

Tivan Limited and Sumitomo Corporation have formalised a joint venture to develop the Speewah Fluorite Project in Western Australia, marking a major step toward establishing Australia’s inaugural fluorite mining and processing operation.

Mayne Pharma has announced the expiration of the US antitrust waiting period, a critical step forward in Cosette Pharmaceuticals' proposed acquisition. The transaction now moves closer to completion, pending other regulatory and shareholder approvals.

Echo IQ has raised $17.3 million through a strongly supported institutional placement to fund US commercialization and FDA approval efforts for its EchoSolv AI cardiology products.

Great Boulder Resources reports outstanding gold recoveries of up to 96% at Mulga Bill with significantly reduced cyanide levels, promising lower processing costs and capital expenditure. The Ironbark scoping study is progressing well, with further drilling underway to expand resources.

Yari Minerals has agreed to acquire the Rolleston South Coal Project, adding a JORC-compliant inferred resource of 78.9 million tonnes in Queensland’s Bowen Basin. The deal includes shares and performance rights, with plans to expand and upgrade the resource through drilling.

TPG Telecom reported robust 2024 financials, expanded its mobile network coverage to 98.4% of Australians, and announced a strategic $5.25 billion fibre asset sale to Vocus Group, setting the stage for a leaner, more agile business in 2025.

CLINUVEL Pharmaceuticals has completed recruitment for its Phase III trial of SCENESSE® in vitiligo patients with darker skin types, setting the stage for first results in late 2026. Early clinical observations suggest promising repigmentation outcomes.